| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
289,870,000 |
| Market
Cap: |
51.39(B) |
| Last
Volume: |
3,277,460 |
Avg
Vol: |
1,512,270 |
| 52
Week Range: |
$165.15 - $249.08 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 9.1 |
| Insider 3/6 Months : 9.7 |
|
| Guru Rank Number : 77 |
| Guru Rank Value : 11.5 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
1,500 |
1,500 |
1,500 |
| Total Buy Value |
$0 |
$350,430 |
$350,430 |
$350,430 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
1,645 |
7,416 |
17,875 |
35,748 |
| Total Sell Value |
$294,105 |
$1,630,849 |
$3,946,054 |
$8,400,247 |
| Total People Sold |
2 |
5 |
6 |
9 |
| Total Sell Transactions |
2 |
9 |
14 |
25 |
| End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mocherla Pavan Kumar |
EVP & President, Greater Asia |
• – – |
2024-11-26 |
4/A |
D |
$0.00 |
$0 |
D/D |
(25) |
2,847 |
|
- |
|
| Shan David |
EVP and Chief ISC Officer |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(124) |
7,785 |
|
- |
|
| Shan David |
EVP and Chief ISC Officer |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,216 |
7,909 |
|
- |
|
| Ezell Antoine C |
EVP, President Americas & CMO |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,357) |
11,970 |
|
- |
|
| Ezell Antoine C |
EVP, President Americas & CMO |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,007 |
13,327 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(196) |
15,494 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,105 |
15,690 |
|
- |
|
| Neal Shana Carol |
EVP and Chief People Officer |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(509) |
17,989 |
|
- |
|
| Neal Shana Carol |
EVP and Chief People Officer |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,109 |
18,498 |
|
- |
|
| Polen Thomas E Jr |
Chairman, CEO and President |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,564) |
100,371 |
|
- |
|
| Polen Thomas E Jr |
Chairman, CEO and President |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
52,124 |
123,935 |
|
- |
|
| Mocherla Pavan Kumar |
EVP & President Greater Asia |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(20) |
2,852 |
|
- |
|
| Mocherla Pavan Kumar |
EVP & President Greater Asia |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,055 |
2,872 |
|
- |
|
| Feld Michael |
EVP & President, Life Sciences |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,553 |
9,190 |
|
- |
|
| Quinn Michelle |
EVP and General Counsel |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(376) |
6,927 |
|
- |
|
| Quinn Michelle |
EVP and General Counsel |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,348 |
7,303 |
|
- |
|
| Delorefice Christopher |
EVP & Chief Financial Officer |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,192) |
21,499 |
|
- |
|
| Delorefice Christopher |
EVP & Chief Financial Officer |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,899 |
26,691 |
|
- |
|
| Byrd Richard |
EVP & President Interventional |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,204) |
9,351 |
|
- |
|
| Byrd Richard |
EVP & President Interventional |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,495 |
10,555 |
|
- |
|
| Garrison Michael David |
EVP & President, Medical |
• – – |
2024-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,230) |
8,979 |
|
- |
|
| Garrison Michael David |
EVP & President, Medical |
• – – |
2024-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,828 |
10,209 |
|
- |
|
| Neal Shana Carol |
EVP and Chief People Officer |
• – – |
2024-11-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(32) |
16,989 |
|
- |
|
| Neal Shana Carol |
EVP and Chief People Officer |
• – – |
2024-11-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
111 |
17,021 |
|
- |
|
| Delorefice Christopher |
EVP & Chief Financial Officer |
• – – |
2024-09-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(466) |
12,792 |
|
- |
|
114 Records found
|
|
Page 1 of 5 |
|
|
0.40 (0.23%) 
